Characteristics and Outcomes of HEDIS-Defined Asthma Patients with COPD Diagnostic Coding

National Committee of Quality Assurance; 2015. Available from: http://www.ncqa.org/HEDISQualityMeasurement.aspx. Accessed September 13, 2015. HEDIS Table SPR-A COPD diagnosis codes. Available from: https://www.vapremier.com/assets/6-PROVIDER-MEASURE-OVERVIEW_2013-with-billing-codes-nat-ranking.pdf (p. 9). Accessed September 13, 2015. HEDIS 2013 Technical Specifications for Physician Measurement. Available from: http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2013/HEDIS_2013_PHYSICIAN_SUMMARY_TABLE_OF_CHANGES.pdf. Accessed September 13, 2015. Hardin, 2011, The clinical features of the overlap between COPD and asthma, Respir Res, 12, 127, 10.1186/1465-9921-12-127 Fernandez-Villar, 2015, Mixed COPD-asthma phenotype: ACOS or CAOS? A reflection on recent guidelines and recommendations [e-pub ahead of print], Arch Bronconeumol Soler, 2015, Are asthma and COPD a continuum of the same disease?, J Allergy Clin Immunol Pract, 3, 489, 10.1016/j.jaip.2015.05.030 Cosio, 2015, Defining the asthma-COPD overlap syndrome in a COPD cohort [e-pub head of print], Chest Bateman, 2015, The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases?, Lancet Respir Med, 3, 719, 10.1016/S2213-2600(15)00254-4 Nielsen, 2015, Clinical characteristics of the asthma-COPD overlap syndrome—a systematic review, Int J Chron Obstruct Pulmon Dis, 10, 1443 Zeiger, 2014, High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma, J Allergy Clin Immunol Pract, 2, 741, 10.1016/j.jaip.2014.06.005 Mosen, 2005, How well do the HEDIS asthma inclusion criteria identify persistent asthma?, Am J Manag Care, 11, 650 Schatz, 2010, Persistent asthma defined using HEDIS versus survey criteria, Am J Manag Care, 16, e281 Schatz, 2006, The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes, Chest, 130, 43, 10.1378/chest.130.1.43 Zeiger, 2010, Step-up care improves impairment in uncontrolled asthma: an administrative data study, Am J Manag Care, 16, 897 Agency for Health Research Quality. Medication management for people with asthma; 2014. Available from: http://www.qualitymeasures.ahrq.gov/content.aspx?id=48617. Accessed September 13, 2015. Schatz, 2006, Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data, J Allergy Clin Immunol, 117, 995, 10.1016/j.jaci.2006.01.053 Zou, 2004, A modified poisson regression approach to prospective studies with binary data, Am J Epidemiol, 159, 702, 10.1093/aje/kwh090 Global Initiative for Asthma; 2014. Available from: http://www.ginasthma.org/documents/4. Accessed September 13, 2015. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic pulmonary disease. Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Updated 2013. Accessed September 13, 2015. Global Initiative for Chronic Obstructive Lung Disease. Diagnosis of diseases o chronic airflow limiation: Asthma, COPD and Asthma-COPD overlap syndrome (ACOS); 2015. Available from: http://www.goldcopd.org/asthma-copd-overlap.html. Accessed September 13, 2015. National Committee for Quality Assurance; 2015. Available from: http://www.ncqa.org/ReportCards/HealthPlans/StateofHealthCareQuality/2015Table of Contents/Spirometry.aspx. Accessed September 13, 2015. Tran, 2014, High blood eosinophil count is associated with more frequent asthma attacks in asthma patients, Ann Allergy Asthma Immunol, 113, 19, 10.1016/j.anai.2014.04.011 Katz, 2014, Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma, Ann Am Thorac Soc, 11, 531, 10.1513/AnnalsATS.201310-354OC Bafadhel, 2011, Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers, Am J Respir Crit Care Med, 184, 662, 10.1164/rccm.201104-0597OC Pascoe, 2015, Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials, Lancet Respir Med, 3, 435, 10.1016/S2213-2600(15)00106-X Eltboli, 2015, Relationship between blood and bronchial submucosal eosinophilia and reticular basement membrane thickening in chronic obstructive pulmonary disease, Respirology, 20, 667, 10.1111/resp.12475 Papi, 2006, Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations, Am J Respir Crit Care Med, 173, 1114, 10.1164/rccm.200506-859OC Siva, 2007, Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial, Eur Respir J, 29, 906, 10.1183/09031936.00146306 Bafadhel, 2012, Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial, Am J Respir Crit Care Med, 186, 48, 10.1164/rccm.201108-1553OC Barker, 2013, Phenotyping the heterogeneity of chronic obstructive pulmonary disease, Clin Sci, 124, 371, 10.1042/CS20120340 Schatz, 2014, Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy, J Allergy Clin Immunol Pract, 2, 570, 10.1016/j.jaip.2014.05.002 Zeiger, 2015, The association of blood eosinophil counts to future asthma exacerbations in children with persistent asthma, J Allergy Clin Immunol Pract, 3, 283, 10.1016/j.jaip.2014.10.009 Barrecheguren, 2015, The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges, Curr Opin Pulm Med, 21, 74, 10.1097/MCP.0000000000000118